Published in Vaccine Weekly, June 10th, 2009
"Many clinical trials involving anti-tumor vaccination have been conducted using modified versions of this peptide. We conducted an in-depth characterization of 210 T-cell receptor beta chain (TRB) clonotypes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly